Pfizer Philippines News and Activities

Pfizer Philippines is owned by Pfizer.

Pfizer is one of the...

• Forbes Global 2000 (#73);
• Fortune 500 (#69);
• Global Fortune 500 (#219);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Pfizer is a company listed under the stock ticker PFE (US).

Pfizer has a direct presence in 39 countries.

Pfizer has 49 subsidiaries including Metsera, Pfizer ANZ and Pfizer Asia.

They are in:

• Pharmaceuticals88%
• Biotechnology12%

Acquisition, funding and merger involving Pfizer.

• Pfizer has acquired Metsera (posted on November 14 2025).
• Pfizer has announced the acquisition of Metsera  (posted on September 24 2025).

View the org chart displaying its 2 main executives

Most searched biographies at Pfizer Philippines

• Edgardo Mendoza, Country Manager, Consumer Healthcare
• Carlos Jose Garcia, Portfolio Manager

Popular executive movements at Pfizer

• Andrew Baum, who is Executive Vice President and Chief Strategy & Innovation Officer will soon leave the company  (posted on April 22 2026).
• David McGettigan, Senior Vice President, Global Business Services, has left the company  (posted on April 20 2026).
• Jean-Marie Geoffroy, Vice President, Sterile Injectables Design, has left the company  (posted on April 20 2026).

Click here to view some more movements at Pfizer

Create your alert
to follow the executive moves at Pfizer Philippines.

Pfizer has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Pfizer Philippines

• Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union | Pfizer
• Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences | Pfizer
• Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older | Pfizer
• Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine | Pfizer
• Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate | Pfizer
• Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age | Pfizer
• Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (containing benzyl alcohol), Due To The Potential Presence of Visible Particulates | Pfizer
• When AI Meets Biology | Pfizer
• Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine | Pfizer
• Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference | Pfizer
• View more press releases Close

Social media about Pfizer Philippines

• Pfizer Philippines on Wikipedia, Google News & Yahoo Finance
• Pfizer Philippines on LinkedIn, X (Twitter) & YouTube